The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index, and 1 are not checked yet; 15 of the 51 sources its claims cite were checked for support.
MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
Open accessAbstract
Substantial data indicate that microRNA 21 (miR-21) is significantly elevated in glioblastoma (GBM) and in many other tumors of various origins. This microRNA has been implicated in various aspects of carcinogenesis, including cellular proliferation, apoptosis, and migration. We demonstrate that miR-21 regulates multiple genes associated with glioma cell apoptosis, migration, and invasiveness, including the RECK and TIMP3 genes, which are suppressors of malignancy and inhibitors of matrix metalloproteinases (MMPs). Specific inhibition of miR-21 with antisense oligonucleotides leads to elevated levels of RECK and TIMP3 and therefore reduces MMP activities in vitro and in a human model of gliomas in nude mice. Moreover, downregulation of miR-21 in glioma cells leads to decreases of their migratory and invasion abilities. Our data suggest that miR-21 contributes to glioma malignancy by downregulation of MMP inhibitors, which leads to activation of MMPs, thus promoting invasiveness of cancer cells. Our results also indicate that inhibition of a single oncomir, like miR-21, with specific antisense molecules can provide a novel therapeutic approach for "physiological" modulation of multiple proteins whose expression is deregulated in cancer.
Verified 2026-10-19 · 1 reference not checked yet
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
miR-21 is elevated in high-grade gliomas and promotes glioma invasion by directly targeting the MMP inhibitor RECK and indirectly regulating TIMP3, leading to increased MMP activity. Inhibiting miR-21 raises RECK/TIMP3, reduces MMP activity in vitro and in vivo, and decreases glioma cell motility and invasion, partly rescued by RECK knockdown.
Key findings
- miR-21 levels remain low in grade II gliomas and most grade III tumors but are significantly higher in GBMs; RECK mRNA is significantly lower in GBMs than normal brain and grade II/III gliomas, and TIMP3 mRNA tends to be lower in GBMs.
- Anti-miR-21 treatment changed expression of ∼570 genes (P < 0.05); upregulated transcripts were enriched for miR-21 seed hexamers (expectations 1.45e−09, 1.37e−14, and 1.82e−12), and at least 65 mRNAs were upregulated by anti-miR-21 and downregulated by miR-21 overexpression.
- miR-21 inhibition increased RECK mRNA ∼2-fold and TIMP3 mRNA about 1.6-fold; RECK was validated as a direct miR-21 target by luciferase reporter, whereas TIMP3 was not consistently directly responsive and is likely downstream.
- miR-21 inhibition reduced MMP-2 activity in A172 and U87 cells and lowered MMP activity in U87 subcutaneous tumors in nude mice; it also reduced scratch motility and Matrigel invasion, with reduced motility partly rescued by RECK siRNA and reduced invasion not observed when anti-miR-21 was cotransfected with RECK siRNA.
Methods
- Human glioma cell lines A172, U87, and LN229 (high miR-21), plus HeLa, MCF7, and U2OS cells, and human nonneoplastic brain and tumor samples; cells were transfected with 2′-O-MOE anti-miR-21, mismatch/control oligonucleotides, synthetic miR-21 duplex, or RECK siRNA.
- mRNA profiling used Agilent 44K arrays at 6 and 24 h posttreatment, with qRT-PCR, Western blot, luciferase 3′ UTR reporter assays with mutated miR-21 binding sites, gelatin zymography, scratch migration, and Matrigel invasion assays.
- In vivo, U87 cells transfected with anti-miR-21 or control were implanted subcutaneously in nude mice; MMP activity was imaged with MMPSense 680 at 3 days after implantation and 24 h later, with caliper tumor measurements.
Limitations
- Stated by the authors: the 2′-O-MOE anti-miR-21 did not significantly or consistently change glioma cell viability or reduce subcutaneous U87 tumor growth; subcutaneous U87 tumors are noninfiltrative, noninvasive, and poorly vascularized, so they are not an accurate model for studying invasiveness and tumor growth; nucleic acid chemistry can profoundly alter cellular responses to miRNA inhibition; therapeutic potential requires future research.
- Stated/evident from the text: the TIMP3 3′ UTR reporter did not consistently respond to miR-21 changes, so TIMP3 is likely a downstream effector rather than a direct target; RECK protein bands were not detectable by Western blot in U87 cells despite ∼2-fold RECK mRNA upregulation.
- Evident from the text: in vivo imaging was performed within the first week, when anti-miR-21 did not affect subcutaneous U87 tumor growth; comparison with a prior intracranial LNA-DNA anti-miR-21 study is limited because tumor locations differed.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 of 51 cited sources checked · 11 supported · 0 flagged · accuracy not yet measured
Every source the paper cites for this claim was checked and supports it.
In the paper
“Among the molecules tested, the 2′-O-MOE ASO was the most potent in repressing miR-21 activity (Fig. 2A), in agreement with previous data (10), whereas the uniform 2′-O-methyl ASO was the least potent, and mixed locked nucleic acid (LNA)-DNA oligonucleotides were variable (data not shown).”
What the sources say
- Supportedcites [10] source
The Discussion explicitly identifies the uniformly modified 2′-O-MOE-PO oligonucleotide as the best anti-miRNA ASO tested. This supports the attributed comparison for miR-21 activity, although the passage specifies the oligonucleotide’s backbone as PO. (LLM, conf=0.94)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Concurring with previously published reports (12, 46), our data indicate that these MMP inhibitors regulate MMP activity posttranslationally.”
What the sources say
- Supportedcites [12] source
The paper describes TIMPs as inhibitors of metalloproteinase activity and shows that TIMP-3 controls the cell-surface activation of pro-MMP-2 (Abstract and Discussion; page numbers unavailable). Its gene-expression analysis found comparable MMP-2 levels in wild-type and TIMP-3-deficient cells despite altered processing, supporting regulation after translation. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [46] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: MMPs are a group of peptidases involved in degradation of the ECM.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, we have not detected any correlation between miR-21-modulated expression in several glioma cell lines and protein level of phosphatase and tensin homolog (data not shown), the reported miR-21 target in hepatocellular carcinomas (44).”
What the sources say
- Supportedcites [44] source
The citation supports the identification of PTEN as a reported miR-21 target in hepatocellular carcinoma: the Results state that PTEN was shown to be a direct target of miR-21 in HCC cells. The preceding statement about no correlation in glioma cell lines is the citing authors’ own unpublished observation, not a finding attributed to this source. (LLM, conf=0.94)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Our data suggest that this can be at least partly due to miR-21 regulation, in addition to the reported chromosome 12q22-23 loss of heterozygosity and hypermethylation (56).”
What the sources say
- Partly supportedcites [56] Watanabe T., 2003, Brain Pathol. sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) reports chromosome 12q22–23 loss of heterozygosity in glioblastomas and its association with low Apaf-1 expression. It mentions hypermethylation only as a possible mechanism in some malignancies; the reported study did not measure it in glioblastomas. The miR-21 proposal is presented as the citing authors’ own conclusion, not as a finding attributed to this source. (LLM, conf=0.83)
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In gliomas, APAF1 is often inactivated or downregulated (56).”
What the sources say
- Partly supportedcites [56] Watanabe T., 2003, Brain Pathol. sourceExperimental — accuracy not yet measured
The Abstract reports low APAF1 mRNA and protein expression in many glioblastomas with chromosome 12q22–23 loss of heterozygosity. The study examined glioblastoma, however, so it does not establish that APAF1 is often inactivated or downregulated across gliomas generally. (LLM, conf=0.85)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The numbers of invasive A172 and U87 cells in cultures with inhibited miR-21 were significantly reduced relative to those in cultures transfected with the control oligonucleotide (Fig. 7A and B).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Specific inhibition of miR-21 with antisense oligonucleotides leads to elevated levels of RECK and TIMP3 and therefore reduces MMP activities in vitro and in a human model of gliomas in nude mice.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moreover, downregulation of miR-21 in glioma cells leads to decreases of their migratory and invasion abilities.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“RECK mRNA expression was significantly lower in GBMs than in normal brain tissue and, especially, in grade II and III gliomas.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When miR-21 was suppressed, the amount of gelatin digested that reflects the levels of MMP-2 proteolytic activity was significantly reduced relative to the amount for the cells transfected with the control oligonucleotide (Fig. 5A).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 28
- Probably not a substantial claim. 21
- The quote only partly states this claim. 2
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Accumulated data suggested that MMP levels and activities are significantly elevated in human gliomas, which contributes to glioma cell invasion of the surrounding normal tissues, metastasis, and angiogenesis through cell surface ECM degradation (21, 45).”
What the sources say
- Not checked — no full text of the sourcecites [21] Hu B., 2003, Proc. Natl. Acad. Sci. USA source
- Partly supportedcites [45] sourceExperimental — accuracy not yet measured
The Abstract and §4.1 link elevated MMP levels in human gliomas to invasiveness, and describe ECM degradation and cell-surface activation. But the Abstract discusses metastasis in cancer generally, not specifically gliomas; §4.2 links MMP-9 to angiogenesis only tentatively and says its activity in invasive glioma tissue is unproven. The copy therefore does not establish significantly elevated MMP activities across human gliomas or the claimed glioma metastasis and angiogenesis mechanism. Page numbers were not supplied. (LLM, conf=0.88)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: MMPs are a group of peptidases involved in degradation of the ECM.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“TIMP3 is a tissue inhibitor of MMPs that inhibits angiogenesis and tumor cell infiltration and also induces apoptosis (2, 48).”
What the sources say
- Partly supportedcites [2] sourceExperimental — accuracy not yet measured
The paper’s Summary (p. 1347) identifies TIMP-3 as a tissue inhibitor of metalloproteinases, and its discussion reports inhibited invasion of HeLa and HT1080 cancer cells and apoptotic death in three cancer cell lines. The copy does not report that TIMP-3 inhibits angiogenesis; searches for angiogenesis and blood-vessel formation found no supporting passage. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [48] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“This microRNA has been implicated in various aspects of carcinogenesis, including cellular proliferation, apoptosis, and migration.”
- Also stated in: § Abstract · plain
“miR-21 has been identified in controlling apoptosis, cell proliferation, and migration of cell lines in breast, colorectal, and other cancers (1, 44, 51, 59).”
What the sources say
- Not checked — no full text of the sourcecites [1] source
- Supportedcites [44] source
The Results report that changing miR-21 expression affects proliferation and migration in HCC cells. The Discussion also reports anti-apoptotic properties of miR-21 in glioblastoma and cholangiocarcinoma, supporting the broader statement that it has been implicated in all three processes. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [51] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Also stated in: § Abstract · plain
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Our analysis also confirmed tropomyosin 1 (TPM1) regulation by miR-21, previously reported to occur in MCF7 cells (59, 60).”
What the sources say
- Supportedcites [59] source
The Abstract reports that experiments using tumors derived from MCF-7 cells identified TPM1 as a miR-21 target and confirmed that miR-21 down-regulates its expression. The Results section also reports increased endogenous TPM1 in anti-miR-21-treated, MCF-7-derived tumors. The paper therefore supports the cited prior report, although its tumor measurements were made in MCF-7-derived tumors rather than isolated cells. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [60] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Another factor that can induce miR-21 expression is hypoxia, a general feature of all solid tumors (30).”
What the sources say
- Supportedcites [30] source
The Results report miR-21 among the hypoxia-regulated microRNAs and say its microarray result was checked by quantitative RT-PCR. The introductory passage describes hypoxia as an essential feature of the neoplastic microenvironment. (LLM, conf=0.90)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The miR-21 gene contains two conserved STAT3 binding sites within its enhancer region and is induced by interleukin 6 (IL-6) in a STAT3-dependent way.”
What the sources say
- Supportedcites [39] source
The Results and discussion section identifies two conserved Stat3 binding sites in the miR-21 upstream regulatory region. It also reports that IL-6 increased miR-21 expression and that Stat3 knockdown inhibited this induction. (LLM, conf=0.94)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“MMPs can degrade ECM components and therefore play important roles in mediating GBM tumor cell motility and invasion (45).”
What the sources say
- Supportedcites [45] source
The Introduction says MMPs can degrade nearly all ECM macromolecules in the brain and are believed to play a major role in tumor invasion. The Abstract links MMP-mediated ECM degradation to glioblastoma invasion, while Section 4 describes how ECM degradation may permit glioma-cell migration. (LLM, conf=0.92)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“APAF1 (apoptotic protease activating factor 1) is the molecular core of apoptosome. It is typically required for activation of the caspases that initiate apoptosis (3, 26).”
What the sources say
- Supportedcites [3] source
The Introduction describes Apaf-1 oligomerization as forming the apoptosome, while the Results and discussion state that Apaf-1 normally recruits and activates caspases-9 and -3. The Concluding remarks add that caspase-9 activity depends on interaction with oligomerized Apaf-1. Page numbers are not provided in our copy. (LLM, conf=0.90)
- Supportedcites [26] Johnson C. E., 2007, Proc. Natl. Acad. Sci. USA source
The paper’s introductory discussion (page not specified in our copy) says cytochrome c binds Apaf-1, leading to recruitment of procaspase-9 and formation of the apoptosome; the apoptosome then activates caspase-9. In the section on Apaf-1 expression levels (page not specified), adding Apaf-1 enabled cytochrome c to activate caspases in neural extracts, supporting its required role in the pathway described. (LLM, conf=0.91)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Elevated miR-21 expression has been causally linked to proliferation, apoptosis, and migration of several cancer cell lines (1, 5, 44, 60).”
What the sources say
- Not checked — no full text of the sourcecites [1] source
- Not checked — no full text of the sourcecites [5] source
- Supportedcites [44] source
The Results report that experimentally increasing or inhibiting miR-21 changed proliferation and migration in HCC cell lines. The Discussion reports anti-apoptotic properties of miR-21 in glioblastoma and cholangiocarcinoma, supporting the apoptosis part as a finding the paper reports from other studies. (LLM, conf=0.87)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“miR-21 levels remain low in grade II gliomas and in most grade III tumors and are significantly higher in GBMs (Fig. 1).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“This expression pattern is different from those of the other cancer-associated miRNAs, for example, miR-10b, which is often elevated in grade III and even grade II gliomas (Fig. 1) and dysregulated in some other cancers (41).”
What the sources say
- Not checked — no full text of the sourcecites [41] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“RECK mRNA level increased consistently ∼2-fold and TIMP3 mRNA about 1.6-fold in the cells transfected with anti-miR-21.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These experiments demonstrated that inhibition of miR-21 reduced the motility of glioma cells (Fig. 6B and C).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe quote only partly states this claim.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“We note that, though 2′-O-MOE miR-21 ASO induced many proapoptotic and cell cycle arrest genes (Fig. 2C; also see Table S1 in the supplemental material), it did not significantly and consistently change the viability of glioma cell lines, which was reported for other, less potent miR-21 inhibitors (5, 8).”
What the sources say
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“STAT3, the other gene that may play a tumor suppressor function in GBM (11), is also negatively regulated by miR-21 according to the microarray data (see Table S1 in the supplemental material) and is a predicted miR-21 target (29, 34).”
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As identified in our study, TIMP3 or both TIMP3 and RECK are also induced by anti-miR-21 in MCF7 (breast carcinoma) and U2OS (osteosarcoma) cells (Fig. 4D).”
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In glioma progression from less invasive grade II gliomas to very invasive GBMs, RECK and TIMP3 levels drop (Fig. 4B), whereas miR-21 expression increases (Fig. 1).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Here, we show that a 2′-O-MOE ASO not only is potent but also upregulates miR-21 seed-containing mRNAs (Fig. 2 and 3).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Substantial data indicate that microRNA 21 (miR-21) is significantly elevated in glioblastoma (GBM) and in many other tumors of various origins.”
- Also stated in: § Abstract · boosted
“Using high-throughput profiling of miRNA expression, we have previously identified a specific miRNA, miRNA 21 (miR-21), as most strongly elevated in nearly all analyzed human GBM specimens (5).”
- Also stated in: § Abstract · boosted
“Other groups demonstrated overexpression of this miRNA in a wide range of other cancers, including breast, lung, colon, prostate, pancreas, ovarian, and stomach cancers, as well as in chronic lymphocytic leukemia (33, 54).”
What the sources say
Strength:boosted· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Abstract · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“mRNAs carrying RECK and TIMP3 are predicted conserved miR-21 targets with one and two putative binding sites, respectively (Fig. 4A).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The sequences of the control and mismatch oligonucleotides have been analyzed using BLAST searches to exclude potential hits in the human transcriptome.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“RECK is a membrane-anchored MMP inhibitor whose reduced expression or inactivation seems to be critical for the invasiveness and metastasis of various cancers, including glioma cancer (7, 46).”
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The high level of miR-21 expression in GBMs compared to that in anaplastic astrocytomas suggests the involvement of miR-21 in one of these key processes.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe quote only partly states this claim.
In the paper
“Its expression level is also an important prognostic factor for multiple cancer types (6).”
What the sources say
- Not checked — no full text of the sourcecites [6] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“It has been demonstrated to inhibit MMP activity and tumor growth in malignant gliomas in vivo (31, 32).”
What the sources say
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Since modified oligonucleotides can induce a wide range of nonspecific, off-target-mediated effects, several ASO molecules of different chemistries have been used for miR-21 inhibition.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our data suggest that miR-21 contributes to glioma malignancy by downregulation of MMP inhibitors, which leads to activation of MMPs, thus promoting invasiveness of cancer cells.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: MMPs are a group of peptidases involved in degradation of the ECM.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Such overrepresentation of the hexamers suggests an abundance of direct miR-21 targets among the genes upregulated by 2′-O-MOE anti-miR-21 and indicates that the effects of this molecule on glioma cells are indeed mediated through the miR-21 pathway.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“These experiments have been performed with the miR-21 inhibitor and with a mismatched control oligonucleotide to ensure that any observed effects are driven by miR-21.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“Importantly, it inhibits tumor necrosis factor alpha-converting enzyme and induces apoptosis through the stabilization of tumor necrosis factor alpha receptors on the cell surface (42).”
What the sources say
- Not checked — no full text of the sourcecites [42] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moreover, it leads to reduction of glioma cell motility and invasion, which is mediated by elevated RECK expression and was partly rescued by RECK siRNA (Fig. 6 and 7).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This implies that miR-21 regulates RECK and TIMP3 expression and thus MMP activities and glioma tumor invasiveness.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In this study, we have demonstrated in vitro and in vivo, using U87 glioma xenografts in nude mice, that miR-21 regulates MMPs and glioma cell invasiveness by directly controlling the MMP inhibitor RECK.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These combined results indicate that miR-21 regulates overlapping though not identical sets of genes in different cells and therefore shares common signaling pathways in different cancers.”
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The APAF1 3′ UTR contains a strong miR-21 binding site (9-mer binding at miR-21 5′ end), and therefore, it is likely one of the direct miR-21 targets.”
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Its expression is highly upregulated in a variety of solid tumors, including GBM, breast, lung, colon, prostate, pancreas, and stomach cancers (5, 54).”
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our mRNA expression analysis suggests that miR-21 regulates the expression of multiple mRNA targets and thereby induces several cellular programs in glioma cells, including those associated with the tumor invasiveness and microvascular proliferation typical for the GBM as well as those involved in cell cycle regulation and apoptosis.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Its ectopic expression in glioma cells induces upregulation of genes associated with angiogenesis, growth factors, cytokines, death receptors, and substrates of the various MMPs (31).”
What the sources say
- Not checked — no full text of the sourcecites [31] Lam P., 2005, Mol. Ther. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“RECK, a membrane-anchored regulator, and TIMP3, the ECM-bound protease regulator, are key inhibitors of several MMPs, and their expression is prognostic in a number of common cancers (28, 53).”
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“TIMP3 has been demonstrated to activate caspases and therefore induce apoptosis of human glioma cells in vitro and the growth inhibition of human glioma tumors in a mouse model (31, 32).”
What the sources say
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Though mRNA expression analysis does not allow identification of targets whose translation is regulated without modulation of mRNA levels”
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Such a bidirectional approach to manipulating miR-21 levels enabled narrowing of the lists of regulated genes and identification of those whose expression correlated negatively with miR-21 levels”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In these experiments, we used tumorigenic U87 cells, a common model of human gliomas (23).”
What the sources say
- Not checked — no full text of the sourcecites [23] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
MMPs are a group of peptidases involved in degradation of the ECM.
“MMPs are a group of peptidases involved in degradation of the ECM.”
The paper relies on this without support.
Subcutaneous U87 tumors are noninfiltrative, noninvasive, and poorly vascularized.
“We should also note that subcutaneous U87 tumors are noninfiltrative, noninvasive, and poorly vascularized.”
The paper relies on this without support.
Knowledge of the molecular mechanisms mediating miR-21 function in cancer generally and in gliomas specifically is limited.
“However, our knowledge of the molecular mechanisms mediating miR-21 function in cancer generally and gliomas specifically is limited.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“miR-21 is a well-known miRNA, found to be overexpressed in almost all cancer types, where its upregulation promotes cell proliferation, invasion, and metastatic behavior.”
From Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma (2019) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have proven that PDCD4, HNRNPK and RECK are TSGs among the direct targets of miR-21-5p (13,(27)(28)(29).”
From Functional interaction between miR-505-3p and miR-21 contributes to GBM suppression (2026) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“miR-21 targets several genes such as PDCD4, TIMP3, and RECK, which are key regulators of apoptotic and metastatic pathways (17–23).”
From Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma (2019) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“Our data on the effects of miR-21 enriched exosomes is in agreement with the previous reports demonstrating that overexpressed miR-21 in cell lines can increase the proliferation rate and malignant behavior of the cells (17–23).”
From Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma (2019) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
APAF1 overexpression claim cites a caspase-8 study
MinorIn the APAF1 discussion, the paper attributes apoptosis induced by viral overexpression to APAF1 and cites reference 50. The cited reference instead describes adenovirus-mediated transfer of caspase-8 in combination with a superrepressor of NF-kappaB.
“Its overexpression by viral transduction induces apoptosis in glioma cells and may be beneficial in glioma treatment (50).”
“50.Shinoura, N., N. Yamamoto, Y. Yoshida, A. Asai, T. Kirino, and H. Hamada. 2000. Adenovirus-mediated transfer of caspase-8 in combination with superrepressor of NF-kappaB drastically induced apoptosis in gliomas.”
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Summaries of Affymetrix GeneChip probe level data
Irizarry, R. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng015 · Cited by 4,837
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
Self-citationIn vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro
Liang, C.-C., Park, A. Y., & Guan, J.-L. (2007) · Nature Protocols · doi:10.1038/nprot.2007.30 · Cited by 4,696
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
miRBase: microRNA sequences, targets and gene nomenclature
Griffiths-Jones, S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj112 · Cited by 3,950
John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., & Marks, D. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020363 · Cited by 3,796
Flagged first, then by citations
Research works printed but not linked: 1
- Gao F., 2007, Oncol. Rep., 17, 123
Cited by
Sorted by citations
Items 601–700 of 886
Blood Alterations Preceding Clinical Manifestation of Glioblastoma
Ilhan‐Mutlu, A., Wagner, L., Wöehrer, A., et al. (2012) · Cancer Investigation · doi:10.3109/07357907.2012.725443 · Cited by 18
“Micro-RNA-21 is one of the most intensively studied micro-RNA in cancer biology and was reported to be up-regulated in glioblastoma tissue 7- to 10-folds as compared to normal brain (12, 13).”
BackgroundOptimal control strategies of eradicating invisible glioblastoma cells after conventional surgery
Reyes, A. A. D. L., V, Jung, E., & Kim, Y. (2015) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.1392 · Cited by 18
The microRNA networks of TGFβ signaling in cancer
Sivadas, V. P., & Kannan, S. (2013) · Tumor Biology · doi:10.1007/s13277-013-1481-9 · Cited by 19
“Glioblastoma RECK, TIMP3, p21, PDCD4 [66, 67]”
RUNX 3 is down‐regulated in glioma by Myc‐regulated miR‐4295
Li, X., Zheng, J., Diao, H., & Liu, Y. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12736 · Cited by 18
Translational Implications of MicroRNAs in Clinical Diagnostics and Therapeutics
Sempere, L. F., & Kauppinen, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00340-5 · Cited by 18
Molecular simulation studies of 3,3′-Diindolylmethane as a Potent MicroRNA-21 Antagonist
Hosen, S. M. Z., Junaid, M., Dash, R., Islam, N., Chowdhury, J., Alam, M. J., Nath, S., Shakil, M. S., Azam, A., & Quader, S. (2017) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_266_16 · Cited by 18
“[18-21] Recently, extensive studies are indicating that excessive expression of miR-21 is involved in all known cancer-related processes including tumor genesis, progression, and metastasis.[21-24] Furthermore, improving chemosensitivity to anticancer agents and inducing cell cycle arrest by inhibition of miR-21 1Depa…”
BackgroundClinical applications of microRNAs
Hydbring, P., & Badalian‐Very, G. (2013) · F1000Research · doi:10.12688/f1000research.2-136.v2 · Cited by 18
MiR-30b-5p modulates glioma cell proliferation by direct targeting MTDH
Zhang, D., Liu, Z., Zheng, N., Wu, H., Zhang, Z., & Xu, J. (2018) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2018.02.015 · Cited by 17
Bian, G., Yu, C., Liu, L., Fang, C., Chen, K., Ren, P., Zhang, Q., Liu, F., Zhang, K., Xue, Q., et al. (2018) · Science Signaling · doi:10.1126/scisignal.aat1470 · Cited by 18
Lee, K.-Y., Seo, Y., Im, J. H., Rhim, J., Baek, W., Kim, S., Kwon, J.-W., Yoo, B. C., Shin, S. H., Yoo, H., et al. (2021) · Cancers · doi:10.3390/cancers13020209 · Cited by 18
RECK Is Up-Regulated and Involved in Chondrocyte Cloning in Human Osteoarthritic Cartilage
Kimura, T., Okada, A., Yatabe, T., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091003 · Cited by 17
Li, H., Yuan, S., Yang, M., Zha, H., Li, X., Sun, H., Duan, L., Gu, Y.-Y., Li, A.-F., Weng, Y.-G., et al. (2016) · OncoTarget · doi:10.18632/oncotarget.10433 · Cited by 19
Shen, Z., Liu, X., Chen, C.-X., & Lu, J. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504017x14897158009178 · Cited by 17
Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma
Yu, W., Liang, S., & Zhang, C. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8507-9 · Cited by 17
Isolation of Extracellular Microvesicles from Cell Culture Medium: Comparative Evaluation of Methods
Shtam, T. A., Samsonov, R. B., Volnitskiy, A., et al. (2018) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750818020117 · Cited by 17
Li, Q., Hamdalla, R. H., Dhyani, N., Sun, L., Gao, L., Rudebush, T., Zucker, I. H., & Tian, C. (2025) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2025.05.002 · Cited by 19
MicroRNA-21 Regulates Diametrically Opposed Biological Functions of Regulatory T Cells
Sun, J., Liu, R., He, X., Bian, J., Zhao, W., Shi, W., & Ruan, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.766757 · Cited by 17
Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens
Ilhan‐Mutlu, A., Wöehrer, A., Berghoff, A. S., Widhalm, G., Marosi, C., Wagner, L., & Preusser, M. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1078-6 · Cited by 16
“MicroRNA-21, microRNA-10b, microRNA-221 and microRNA-222 were previously shown to be up-regulated [5, 8, 14], whereas microRNA-181b and microRNA-181c were down-regulated in glioblastoma tissue [9].”
BackgroundOverexpression of tissue microRNA10b may help predict glioma prognosis
Zhang, X., Cheng, J., Fu, L., et al. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.10.046 · Cited by 16
Cerebrospinal fluid biomarkers of malignancies located in the central nervous system
Verheul, C., Kleijn, A., & Lamfers, M. L. M. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804279-3.00010-1 · Cited by 17
Martínez, R. (2012) · Journal of Signal Transduction · doi:10.1155/2012/519807 · Cited by 16
“In contrast, downregulation of miR-21 in glioma cells leads to a reduction in their migratory and invasive capability [88].”
Decreased expression of miR-410-3p correlates with poor prognosis and tumorigenesis in human glioma
Wang, C., Huang, S., Rao, S., Hu, J., Zhang, Y., Luo, J., & Wang, H. (2019) · Cancer Management and Research · doi:10.2147/cmar.s202247 · Cited by 15
What We Learn From Transformation Suppressor Genes: Lessons From RECK
Noda, M., Takahashi, C., Matsuzaki, T., & Kitayama, H. (2010) · Future Oncology · doi:10.2217/fon.10.80 · Cited by 15
Prioritizing cancer-related microRNAs by integrating microRNA and mRNA datasets
Jin, D., & Lee, H. (2016) · Scientific Reports · doi:10.1038/srep35350 · Cited by 15
Ohnishi, Y., Iwatsuki, K., Ishihara, M., Ohkawa, T., Kinoshita, M., Shinzawa, K., Fujimoto, Y., & Yoshimine, T. (2016) · Journal of Neurosurgery Spine · doi:10.3171/2016.8.spine16248 · Cited by 15
miR-215 functions as an oncogene in high-grade glioma by regulating retinoblastoma 1
Meng, X., & Shi, B. (2017) · Biotechnology Letters · doi:10.1007/s10529-017-2373-7 · Cited by 15
Zhang, Y., Zeng, A., Liu, S., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.8280 · Cited by 15
“The results demonstrated that EMT was closely associated with malignant progression in gliomas, as previously proposed (8,9).”
Roles of microRNAs as non-invasive biomarker and therapeutic target in colorectal cancer.
Wan, T. M.-H., Iyer, D. N., & Ng, L. (2020) · PubMed · doi:10.14670/hh-18-171 · Cited by 15
Liu, F., & Yang, B. (2020) · BioMed Research International · doi:10.1155/2020/7930160 · Cited by 14
A major role for microRNAs in glioblastoma cancer stem-like cells
Yang, H. W., Xing, H., & Johnson, M. D. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0574-y · Cited by 15
Significance and Therapeutic Value of miRNAs in Embryonal Neural Tumors
Shalaby, T., Fiaschetti, G., Baumgartner, M., & Grotzer, M. A. (2014) · Molecules · doi:10.3390/molecules19055821 · Cited by 15
LncRNA LINC01140 Inhibits Glioma Cell Migration and Invasion via Modulation of miR-199a-3p/ZHX1 Axis
Xin, Y., Zhang, W., Mao, C., et al. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s230895 · Cited by 15
“Previous studies have demonstrated that lncRNAs could bind with microRNAs (miRNAs, ~22 nt) and exert their roles to affect the growth of human cancers.(24) For example, Cai reported that lncRNA taurine upregulated 1 (TUG1) enhanced tumor angiogenesis by suppressing miR-299 in glioma.”
BackgroundRetractedBarati, S., Yadegari, A., Shahmohammadi, M., Azami, F., Tahmasebi, F., Rouhani, M. R., Kazemi, S., & Asl, E. R. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01884-5 · Cited by 20
“This occurs through the modulation of key pain-related pathways by miR-21, including MMPs and extracellular signal-regulated kinase (ERK) signaling components [169–171].”
The Many Functions of MicroRNAs in Glioblastoma
Chiocca, E. A., & Lawler, S. E. (2010) · World Neurosurgery · doi:10.1016/j.wneu.2010.06.047 · Cited by 14
Insight into the role of microRNAs in brain tumors (Review)
Catania, A. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1305 · Cited by 15
“They confirmed the results of previous studies (29,40), which showed a similar expression pattern of mir-21, mir-124, and mir-137 in gliomas and stem cells.”
ResultLeBlanc, V., & Morin, P. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4081612 · Cited by 13
Role of exosomal small RNA in prostate cancer metastasis
Zhan, F., Shen, J., Wang, R., Wang, L., Dai, Y., Zhang, Y., & Huang, X. (2018) · Cancer Management and Research · doi:10.2147/cmar.s170610 · Cited by 14
Hohmann, T., Feese, K., Greither, T., Ghadban, C., Jäger, V., Dehghani, F., & Hohmann, U. (2019) · Cancers · doi:10.3390/cancers11020161 · Cited by 14
Low microRNA-622 expression predicts poor prognosis and is associated with ZEB2 in glioma
Song, Q., Pang, H., Qi, L., Chen, L., Wang, T., Wang, W. T., & Li, R. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s218161 · Cited by 14
GOLPH3 Regulates Exosome miRNA Secretion in Glioma Cells
Hu, P., Wang, K., Zhou, D., Wang, L., Zhao, M., Wang, W., Zhang, Y., Liu, Y., Yu, R., & Zhou, X. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01535-6 · Cited by 14
“Transcriptional profiling of cells whose miR-21 was knocked down revealed changes in the expression of genes correlated with DNA damage response, regulators of cell cycle arrest, and positive regulators of apoptosis (Gabriely et al. 2008).”
Dietary flavonoid narirutin as a prospective antagonist of oncogenic pri/ pre‐microRNAs
Singh, S., Srivastava, P. N., Meena, A., et al. (2022) · Phytotherapy Research · doi:10.1002/ptr.7367 · Cited by 14
“…metastasis, and tumour genesis as well as downregulation of miR-21 increased the chemosensitivity of tumour cells against the anticancer drugs and induced cell cycle arrest (BautistaSánchez et al., 2020; Gabriely et al., 2008; Medina, Nolde, & Slack, 2010; Qian et al., 2009; Si et al., 2007).”
BackgroundMechanisms of Oncogene Activation
Botezatu, A., Iancu, I. V., Popa, O., Plesa, A., Manda, D. A., Huică, I., Vlădoiu, S., Anton, G., & Badiu, C. (2016) · InTech eBooks · doi:10.5772/61249 · Cited by 15
Avitabile, C., Cimmino, A., & Romanelli, A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5006594 · Cited by 14
Wang, X., Zhang, X., Hua, R., Du, Y., Huang, M., Liu, Y., Cheng, Y., & Guo, W. (2016) · Oncotarget · doi:10.18632/oncotarget.11221 · Cited by 14
“As VEGF and TIMP3 are important positive and negative regulator of cancer cells’ invasion and metastasis, respectively; and TIMP3 is a known target of miR-21 [20], and VEGF was reported as a downstream molecular of Mel-18 [21] and miR-21 [16], we tested whether Mel-18 regulates the expression of these two molecules, a…”
BackgroundHuang, Y.-K., Su, Y., Lieu, A., Loh, J., Li, C., Wu, C., Kuo, K., & Lin, C.-L. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135289 · Cited by 14
Antidepressant hyperforin up-regulates VEGF in CNS tumour cells
Tassone, E., Maran, C., Masola, V., et al. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.09.005 · Cited by 14
MicroRNA biosensors for detection of glioblastoma
Fattahi, M., Maghsudlu, M., Razipour, M., Movahedpour, A., Ghadami, M., Alizadeh, M., Khatami, S. H., Taheri‐Anganeh, M., Ghasemi, H., Ghasemi, H., et al. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.117829 · Cited by 13
MicroRNAs modulation in lung cancer: exploring dual mechanisms and clinical prospects
HUSSAIN, S., Bokhari, H., Fan, X., MALIK, S. I., Ijaz, S., Shereen, M. A., & Fatima, A. (2024) · Biocell · doi:10.32604/biocell.2024.044801 · Cited by 13
Targeting MicroRNAs with Small Molecules
Tadesse, K., & Benhamou, R. I. (2024) · Non-Coding RNA · doi:10.3390/ncrna10020017 · Cited by 14
Alorfi, N. M., Ashour, A. M., Alharbi, A. S., & Alshehri, F. S. (2024) · Medicine · doi:10.1097/md.0000000000038245 · Cited by 14
“[50] NSAIDs may also modulate the inflammatory microenvironment in GBM. Inflammatory mediators released by GBM cells contribute to the establishment of an immunosuppressive microenvironment that promotes tumor growth and invasion.”
BackgroundmiRNAs and their multifaceted role in cutaneous wound healing
Mansour, R. M., Mageed, S. S. A., Awad, F. A., Sadek, M. M., Adel, S. A., Ashraf, A., Alam-ElDein, K. M., Ahmed, N. E., Abdelaziz, R. Y., Tolba, E. F., et al. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01535-y · Cited by 16
“MiR-21 could promote cancer cell migration by targeting reversion-inducing cysteine-rich protein with kazal motifs (RECK), TIMP3, and T-cell lymphoma invasion and metas - tasis 1 (TIAM1) genes (Gabriely et al. 2008; Cottonham et al. 2010 ).”
Crosstalk between kinases, phosphatases and miRNAs in cancer
Abrantes, J. L. F., Tornatore, T. F., Pelizzaro‐Rocha, K. J., de Jesus, M. B., Cartaxo, R. T., Milani, R., & Ferreira‐Halder, C. V. (2014) · Biochimie · doi:10.1016/j.biochi.2014.09.011 · Cited by 14
Prognostic role of circulating microRNA-21 in cancers: evidence from a meta-analysis
Yang, Y., Qian, J.-X., Chen, Y., & Pan, Y. (2014) · Tumor Biology · doi:10.1007/s13277-014-1846-8 · Cited by 13
“However, knockdown or suppression of miR-21 could reduce cell proliferation and invasion by inducing apoptosis [41–44]. miR-21 modulates the expression of multiple tumor suppressor genes including programmed cell death 4 (PDCD4) [41], phosphatase and tensin homolog (PTEN) [43], cell division cycle 25 homolog A (Cdc25a…”
BackgroundmiR-133b acts as a tumor suppressor and negatively regulates EMP2 in glioma
Zhang, Q., FAN, X., Xu, B., et al. (2018) · Neoplasma · doi:10.4149/neo_2018_170510n337 · Cited by 13
“[10] GABRIELY G, WURDINGER T, KESARI S, ESAU CC,”
Ghaemi, S., Fekrirad, Z., Zamani, N., Rahmani, R., & Arefian, E. (2022) · Journal of drug targeting · doi:10.1080/1061186x.2022.2047191 · Cited by 13
Haigl, B., Vanas, V., Setinek, U., Hegedűs, B., Gsur, A., & Sutterlüty, H. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2272 · Cited by 13
“Identified targets, which would explain an important role of miR-21 in invasion and metastasis, are Tropomyosin (42), Reck and TIMP3 (43).”
Identification and Analysis of Intermediate Size Noncoding RNAs in the Human Fetal Brain
Yan, D., He, D., He, S., Chen, X., Fan, Z., & Chen, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021652 · Cited by 13
“MicroRNA-21 is highly expressed in glioma and targets various genes involved in cell proliferation, migration and apoptosis [15,49], and has been linked to glioma development [15,49].”
BackgroundHong, K., Hsu, M., Hou, M., & Hung, W. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.01.021 · Cited by 12
Self-renewal mechanisms in neural cancer stem cells
Mantamadiotis, T. (2010) · Frontiers in bioscience · doi:10.2741/3708 · Cited by 12
Vitale, A. M., Santonocito, R., Vergilio, G., Marino, A., Campanella, C., de Macario, E. C., Bucchieri, F., Macario, A. J. L., & Bavisotto, C. C. (2020) · Applied Sciences · doi:10.3390/app10196961 · Cited by 12
Geranmayeh, M. H., Nourazarian, A., Avcı, Ç. B., Rahbarghazi, R., & Farhoudi, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0286-4 · Cited by 12
“miR-21 ↑ Downregulating MMPs inhibitors RECK and TIMP3, enhancing ECs survival Permeability ↓, promoting cancer cell migration [150, 161, 162]”
BackgroundSynergistic regulatory effects of microRNAs on brain glioma cells
Zhao, Y., Cui, X., Zhu, W., Chen, X., Shen, C., Liu, Z., Yang, G., Liu, Y., & Zhao, S. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6709 · Cited by 12
“The oncogenic miRNA miR‑21 has been observed to be associated with malignant glioma, and its expression level is directly associated with tumor grade; patients with low miRNA‑21 expression exhibit increased survival times and improved clinical outcomes (17).”
Modulation of MicroRNAs for Potential Cancer Therapeutics
Wu, W. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-863-8_5 · Cited by 12
MicroRNA therapeutics in glioblastoma: Candidates and targeting strategies
Mondal, I., Sharma, S., & Kulshreshtha, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815669-8.00010-5 · Cited by 12
Spanò, D. P., & Scilabra, S. D. (2022) · Membranes · doi:10.3390/membranes12020211 · Cited by 13
Attachaipanich, T., Chattipakorn, S. C., & Chattipakorn, N. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-023-04803-2 · Cited by 12
miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma
Jethwa, K. R., Wei, J., McEnery, K., & Heimberger, A. B. (2011) · Clinical Investigation · doi:10.4155/cli.11.159 · Cited by 11
Altered Expression of PTEN and Its Major Regulator MicroRNA-21 in Pulmonary Neuroendocrine Tumors
Lee, H. W., Ha, S. Y., & Roh, M. S. (2014) · Journal of Pathology and Translational Medicine · doi:10.4132/koreanjpathol.2014.48.1.17 · Cited by 11
“It has been demonstrated that miRNA can induce tumorigenesis, for example, by downregulating tumor suppressor genes.(13-17,28) It has been reported that PTEN, an important tumor suppressor, is regulated by multiple miRNAs including miR-21 in various cancers.”
BackgroundMarzulli, M., Mazzacurati, L., Zhang, M., Goins, W. F., Hatley, M. E., Glorioso, J. C., & Cohen, J. B. (2018) · Journal of Gene Therapy · doi:10.13188/2381-3326.1000007 · Cited by 11
“Consistent with these and related findings both in vitro and in vivo [19-23], a variety of predicted or experimentally validated miR-21 targets are involved in cell cycle regulation, apoptosis, cell migration and stem cell self-renewal [24-29].”
BackgroundNikolova, E., Georgiev, C., Laleva, L. N., et al. (2022) · Molecular Genetics and Genomics · doi:10.1007/s00438-021-01851-5 · Cited by 10
“The upregulated miR-21 and miR-10b of our selected signature, have been associated with cell migration and invasion (Gabriely et al. 2008; Grunder et al. 2011; Sheedy and Medarova 2018).”
BackgroundDauricine inhibits human pancreatic carcinoma cell proliferation through regulating miRNAs
Jiang, L., Guo, T., Jiang, Y., et al. (2021) · Molecular Omics · doi:10.1039/d1mo00156f · Cited by 10
The Roles of MicroRNAs in Glioblastoma Biology and Biomarker
Sasayama, T., Tanaka, K., & Kohmura, E. (2016) · InTech eBooks · doi:10.5772/63243 · Cited by 9
“miR-21 TIMP3, RECK up promote cell invasion Gabriely (84), Zhao (86)”
BackgroundInfluentialMicroRNA‐21 and microRNA‐214 play important role in reproduction regulation during porcine estrous
Mi, T., Zhang, X., Zhang, X., et al. (2018) · Animal Science Journal · doi:10.1111/asj.13087 · Cited by 10
Mathur, A., Singh, A., Hussain, Y., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127945 · Cited by 9
MicroRNAs in breast cancer—new frontiers in diagnosis, targeted therapy, and prognosis assessment
Xiao, J., Zhang, L., Su, R., Zhao, B., Dang, Y., Zhao, C., Wang, S., Qi, T., & Ji, F. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1529907 · Cited by 12
“Additionally, miR-21 is overexpressed in breast cancer and contributes to invasion and metastasis by targeting tumor suppressor genes such as PTEN and RECK (71, 72).”
Xie, C., Xu, M. M., Lu, D., Zhang, W., Wang, L., Wang, H., Li, J., Ren, F., & Wang, C. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9231 · Cited by 9
“It was previously reported that the dysregulation of miRNA-21 and miRNA-10b may disrupt the migration of glioma cells and inhibit glioma cell migration and invasion (20).”
BackgroundImpact of Heavy Metals on Glioma Tumorigenesis
Caruso, G., Nanni, A., Curcio, A., Lombardi, G., Somma, T., Minutoli, L., & Caffo, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015432 · Cited by 9
“The increased expression of MIR-21, blocking the apoptotic mechanisms, seems to be responsible for the progression of GB [23].”
BackgroundThe Role of Noncoding RNAs in Prostate Cancer
Hasegawa, T., Lewis, H., & Esquela‐Kerscher, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800553-8.00012-3 · Cited by 9
Up-regulation of TIMP-3 and RECK decrease the invasion and metastasis ability of colon cancer
Wang, J., Lin, Y., Jiang, T., et al. (2019) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2019.07.003 · Cited by 9
MiR-23b Promotes the Migration of Keratinocytes Through Downregulating TIMP3
Hu, H., Tang, J., Liu, C., & Cen, Y. (2020) · Journal of Surgical Research · doi:10.1016/j.jss.2020.03.043 · Cited by 8
Singh, R. R., Kulshreshtha, R., & Popat, A. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03529-1 · Cited by 11
Zam, A., Rouatbi, N., Walters, A. A., & Al‐Jamal, K. T. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115759 · Cited by 13
Following MicroRNAs Through the Cancer Metastatic Cascade
Grisard, E., & Nicoloso, M. S. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.04.005 · Cited by 8
Thyroid Tumor: Investigating MicroRNA-21 Gene Suppression in FTC and FTA
Nwadiugwu, M. C. (2020) · Cancer Informatics · doi:10.1177/1176935120948474 · Cited by 8
Ren, J., Sun, Y., Zhao, X., et al. (2012) · Head & Neck Oncology · Cited by 8
Micro-RNA Feedback Loops Modulating the Calcineurin/NFAT Signaling Pathway
Kannambath, S. (2016) · Non-Coding RNA · doi:10.3390/ncrna2020003 · Cited by 7
“These data thus suggest a potential role of hsa-miR-181c in silencing CSNK1A1, which would activate the NFAT pathway and immune response.”
BackgroundInfluentialJiang, S., Jiang, W., Xu, Y., et al. (2018) · MicroRNA · doi:10.2174/2211536607666180821162850 · Cited by 8
García‐Colmenero, L., González, J., Sandoval, J., Guillén, Y., Díaz‐Lagares, Á., Andrades, E., Iglesias, A., Nonell, L., Pujol, R. M., Bigas, A., et al. (2020) · Cells · doi:10.3390/cells9122692 · Cited by 8
“Additionally, GSEA showed that MYC and E2F target genes were downregulated in miR124-transduced cells, and these cells display expression dynamics comparable to that observed after miR-21 inhibition in glioma cells [43,44] (Figure 3C).”
BackgroundNanoparticles for Brain Drug Delivery
Veloso, S. R. S., Ferreira, P. M. T., Martins, J. A., Coutinho, P. J. G., & Castanheira, E. M. S. (2020) · doi:10.1201/9781003119326 · Cited by 8
Novel genomic methods for drug discovery and mechanism-based toxicological assessment.
Gant, T. W., Zhang, S., & Taylor, E. (2009) · PubMed · Cited by 8
Aggarwal, A., Singla, N., Konar, M., et al. (2024) · Tuberculosis · doi:10.1016/j.tube.2024.102501 · Cited by 7
Gupta, M. K., Jayaram, S., Reddy, S. D. N., et al. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00765 · Cited by 7
Targeted Gene Candidates for Treatment and Early Diagnosis of Age‐Related Macular Degeneration
Çinici, E., Çağlar, Ö., Arslan, M. E., Dilekmen, N., Utlu, B., Mardinoğlu, A., & Türkez, H. (2021) · BioMed Research International · doi:10.1155/2021/6620900 · Cited by 7
“TIMP3 5′-TATGACTAGTAGCCCAGTGATGCTTGTGT TG-3′ 5′-TATGAAGCTTATTCAGGAAAATGGCGGCATG TG-3′ [61]”
Meng, W.-M., Cao, X., Sun, W., et al. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.5050 · Cited by 7
Genetics and pharmacogenomics of diffuse gliomas
van Thuijl, H. F., Ylstra, B., Wurdinger, T. D., et al. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.002 · Cited by 7
“miR-21 was found to be highly expressed in GBMs and its inhibition led to reduced migration and invasion by targeting inhibitors of metalloproteinases (Corsten et al., 2007; Gabriely et al., 2008; Papagiannakopoulos et al., 2008).”
BackgroundSelf-citationMicroRNAs Function as Tumor Suppressor Genes and Oncogenes
Esquela‐Kerscher, A. (2010) · Modecular medicine and medicinal · doi:10.1142/9781848163676_0006 · Cited by 7
Yin, P., Sun, Y., Chen, H.-P., et al. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2015.1044088 · Cited by 7
“In pancreatic cancer and malignant gliomas, miR-21 contributes to the exacerbation of disease via the down-regulation of MMP inhibitors, which leads to the activation of MMPs and promotes the invasiveness of cancer cells [37,38].”
BackgroundIntegrative Analysis of miR-21, PTEN, and Immune Signatures in Colorectal Cancer
Yen, Y., Hsu, C.-I., Chen, Y., & Tsai, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412118 · Cited by 6
“It promotes tumor growth, invasion [7], and therapy resistance [8], primarily by repressing tumor suppressors such as the phosphatase and tensin homolog (PTEN) [9].”
Hiraku, Y., Watanabe, J., Kaneko, A., Ichinose, T., & Murata, M. (2021) · Journal of Occupational Health · doi:10.1002/1348-9585.12282 · Cited by 6
MicroRNAs in Colorectal Cancer
Slabý, O., Svoboda, M., Michálek, J., et al. (2010) · Springer eBooks · doi:10.1007/978-94-007-0298-1_4 · Cited by 6
Metadata
- Authors
- Gabriely, G., Wurdinger, T., Kesari, S., Esau, C. C., Burchard, J., Linsley, P. S., & Krichevsky, A. M.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Regulus Therapeutics (United States) (US)
- Corresponding author
- Krichevsky, Anna M.
- ORCID
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2008-09-01
- Volume
- 28
- Issue
- 17
- Pages
- 5369-5380
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2519720
- OpenAlex
- W2163655902
- Cited by
- 888
- References
- 62
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 21 · 2023: 29 · 2022: 20 · 2021: 21 · 2020: 43 · 2019: 41 · 2018: 33 · 2017: 56 · 2016: 56 · 2015: 75 · 2014: 76 · 2013: 86 · 2012: 91
- FWCI
- 21.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- PubMed Central (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- National Institutes of Health (CA86355)
- National Cancer Institute (R21 CA116141, P50 CA86355-04, P50CA086355)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Keywords
- miR-21, glioma invasion, glioblastoma, matrix metalloproteinases, RECK, TIMP-3, matrix metalloproteinase inhibitors, cell migration, apoptosis, antisense oligonucleotides, microRNA inhibition, tumor malignancy
- MeSH terms
- Animals, Base Sequence, Cell Movement, Enzyme Inhibitors, Extracellular Matrix, Glioma, Humans, Molecular Sequence Data, Neoplasm Invasiveness, Neoplasm Transplantation, RNA, Messenger, Down-Regulation, Gene Expression Regulation, Neoplastic, Apoptosis, Disease Progression, Oligonucleotide Array Sequence Analysis, Matrix Metalloproteinases, Gene Expression Profiling, MicroRNAs, Cell Line, Tumor, Mice, Genes, Neoplasm, Matrix Metalloproteinase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review